SCHEMBL3349867

SCHEMBL3349867

CC([C@@H]1C[C@@H](CN2CCCCC2)C1(C)C)N1CCc2ccccc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CXCR3 P49682 1/20 0.38
HRH3 Q9Y5N1 4/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
LMNA P02545 2/20 0.36
METAP1 P53582 2/20 0.36
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
KCNH2 Q12809 1/20 0.35
OGA O60502 1/20 0.34
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
PRMT5 O14744 1/20 0.33
WDR77 Q9BQA1 1/20 0.33
CARM1 Q86X55 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRG2 P18507 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18723744 0.80 CXCR3 (0.42) CXCR3
SCHEMBL3993586 0.74 CXCR3 (0.45) CXCR3HRH3ALDH1A1KDM4E
SCHEMBL18691809 0.65 ARG1 (0.34)
SCHEMBL1083820 0.65 MAOA (0.57) MEN1KMT2AHRH3ALDH1A1TSHR
SCHEMBL30561536 0.65 MAOA (0.57) MEN1KMT2AHRH3ALDH1A1TSHR
SCHEMBL3318467 0.64 HTR7 (0.45) CXCR3ALDH1A1KDM4EPRMT5WDR77
SCHEMBL18723564 0.63 SIGMAR1 (0.40) TSHRKCNH2
SCHEMBL2632966 0.63 MAOA (0.50) MEN1KMT2AHRH3ALDH1A1TSHR
SCHEMBL20756303 0.63 MAOA (0.50) MEN1KMT2AHRH3ALDH1A1TSHR
SCHEMBL12230334 0.62 MAPT (0.55) MEN1KMT2AHRH3ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100105680-A1 SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105680-A1 SUBSTITUTED DIMETHYLCYCLOBUTYL COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS SIGMAR1, TMEM97, OPRK1 MEN1 1239/4885KMT2A 3217/4885CXCR3 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.